Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This case study identified low iron stores, potentially linked to heavy menstrual periods, as a trigger for diffuse nonscarring alopecia in a 31-year-old woman, leading to a diagnosis of telogen effluvium, for which iron supplementation was prescribed.

This review summarizes expert opinions on the use of approved pharmacologic treatments alongside hair transplantation, highlighting their potential to enhance hair density and regrowth speed while reducing further hair loss, but reports no new clinical trial results.

This article discusses surgical hair restoration using micrografting techniques, emphasizing its ability to produce natural-looking results without the "hair plug" appearance, and reports no new clinical findings.

Hair growth dysfunction involves various conditions with limited treatment options.

In this pilot study, topical latanoprost acid was observed to increase hair count and improve hair follicle structure in women with androgenetic alopecia, with no serious adverse events, suggesting potential for further investigation to confirm its efficacy and safety.

This review discusses the potential impact of lifestyle factors on the progression of androgenetic alopecia and reports no new clinical findings; the authors emphasize the need for more comprehensive studies.

This study found that women with telogen effluvium had significantly lower serum ferritin levels compared to healthy controls, suggesting an association between iron deficiency and this form of hair loss.

This study assesses the impact of teaching programs on the knowledge of waste management among women, but results are not reported in the abstract.

In this case report, a woman with unexplained hair loss and high ANA levels developed systemic lupus erythematosus, highlighting the importance of monitoring autoantibodies for early lupus detection and management.

This study found that elevated luteinizing hormone levels were significantly associated with female pattern hair loss, and implicated LH/LHR signaling in the aging and damage of hair follicles.

This hospital-based cross-sectional study found that a substantial proportion of women with female pattern hair loss also had metabolic syndrome, with no significant differences in frequency across age, disease duration, or hair loss pattern subgroups.

This study found topical finasteride and minoxidil both improved hair loss clinically and trichoscopically more effectively than spironolactone in women with female pattern hair loss.

This article reports the first documented cases of Marie-Unna hereditary hypotrichosis in Egypt, highlighting the variability of genetic mutations in this rare form of congenital hair loss.

This study found a significant association between increased waist circumference and body mass index and female pattern hair loss in premenopausal women, suggesting the importance of screening for metabolic syndrome in these patients.

The book provides comprehensive treatment strategies for female hair loss.

This study found that three sessions of injectable platelet-rich fibrin (i-PRF+) significantly improved hair follicle density, hair volume, and thickness, as well as patient satisfaction in women with female pattern hair loss, with only minor self-limited adverse effects reported.

This study highlights the lack of sufficient Korean epidemiological research examining the psychosocial aspects of female pattern hair loss, the leading cause of hair loss among women.

A new computer tool quickly measures hair thickness differences in people with common types of hair loss.

This study found that oral iron supplementation, when given with topical 3% minoxidil, does not outperform the use of topical 3% minoxidil alone in treating female pattern hair loss and iron deficiency.

This study found that Dr. SKS Hair Booster Serum significantly improved hair shaft diameter, terminal hair counts, and hair growth rate in women with PCOS experiencing female pattern hair loss, without any reported adverse events, over a six-month treatment period.

In this study, the Hamilton-Norwood subtype of female pattern hair loss was associated with early onset and polycystic ovary syndrome, while the Ludwig pattern was more common overall.

This study found that among mixed connective tissue disease patients in a tertiary care hospital in Pakistan, Raynaud phenomenon was the most common clinical feature, present in 80% of patients.

This study found that dermoscopy can help differentiate between types of diffuse alopecia in females, with yellow dots common in telogen effluvium and hair diameter diversity over 20% significant in female androgenetic alopecia.

This case report describes a 19-year-old female with systemic lupus erythematosus who exhibited eyelash trichomegaly, a rare disorder involving changes in eyelash characteristics, alongside diffuse alopecia.

In this study, researchers observed an increased incidence of pattern hair loss and telogen effluvium among COVID-19 patients, potentially linked to psychological stress, systemic inflammation, and oxidative stress, with reduced anagenic expression of proteoglycans suggested as a mediating mechanism.

In this survey of dermatologists in India, most participants reported that nutritional deficiencies are common in alopecia patients and preferred using serum peptide formulations, rating them as "very good" or "good" for efficacy, with Folliserum receiving high marks for aesthetics.

This discussion highlights the evolving clinical spectrum of lichen planopilaris, noting atypical features and presentations in younger males that suggest potential different pathomechanisms from previously recognized variants.

This review discusses telogen effluvium in women and suggests that combining minoxidil with supplementary therapies may enhance treatment outcomes, but it reports no new clinical results.

Male pattern baldness is a common hair loss in men caused by genetics and hormones, with treatments including drugs, hair transplants, and hair loss products.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.